MedTrace Logo

Oxaliplatin and 5-FU Based Preoperative Chemoradiation

NCT00278694 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 109

Last updated 2016-09-29

No results posted yet for this study

Summary

Oxaliplatin and 5FU based preoperative chemoradiation in rectal cancer.

Conditions

Interventions

DRUG

Oxaliplatin

DRUG

Chemoradiation

DRUG

5-FU

RADIATION

Preoperative chemoradiation

PROCEDURE

Pelvic surgery

DRUG

Neoadjuvant oxaliplatin

Sponsors & Collaborators

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Georg Høyer, DH · South region committee for research ethics in Norway

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-30
Primary Completion
2016-02-29
Completion
2016-02-29

Countries

  • Norway

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00278694 on ClinicalTrials.gov